Yildirim, B. Et Al. 2019. The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.. ASCO-SITC Clinical Immuno-Oncology Symposium , (San-Francisco, Costa Rica).

Yildirim, B., Cem, O., Kose, F., Oymak, E., Sedef, A. M., Besen, A. A., ... Aksoy, S.(2019). The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. . ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica

Yildirim, Berna Et Al. "The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.," ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica, 2019

Yildirim, Berna Et Al. "The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.." ASCO-SITC Clinical Immuno-Oncology Symposium , San-Francisco, Costa Rica, 2019

Yildirim, B. Et Al. (2019) . "The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.." ASCO-SITC Clinical Immuno-Oncology Symposium , San-Francisco, Costa Rica.

@conferencepaper{conferencepaper, author={Berna Yildirim Et Al. }, title={The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.}, congress name={ASCO-SITC Clinical Immuno-Oncology Symposium}, city={San-Francisco}, country={Costa Rica}, year={2019}}